Eli Lilly and Company Reports Third-Quarter 2013 Results

Published: Oct 23, 2013

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

INDIANAPOLIS, Oct. 23, 2013 /PRNewswire via COMTEX/ -- -- Worldwide revenue increased 6 percent, driven by solid growth for Cymbalta, insulins, Animal Health, Alimta, Cialis and Trajenta.

-- Higher revenue and ongoing cost containment drove strong operating income growth.

-- Earnings per share totaled $1.11 for the third quarter of 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news